Overview +

Uterine Cancer Plasma | High-Quality Human Plasma from Uterine Cancer Donors

Uterine Cancer Human Plasma is collected from donors clinically diagnosed with uterine cancer and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human uterine cancer plasma supports research focused on biomarker discovery and monitoring, inflammation profiling, and therapeutic development for uterine cancer.

Product Features

  • Research Use Only (RUO)
  • Uterine cancer human plasma collected from clinically confirmed donors
  • Processed within one day of collection
  • IRB-approved protocols and informed consent
  • Custom aliquot volumes available upon request

Donor Metadata

  • Verified uterine cancer diagnosis
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Donor-reported medications, allergies, and comorbidities
  • Additional uterine cancer-specific metadata available

Applications

  • Biomarker discovery and validation
  • Cytokine and inflammation profiling
  • Metabolomics and proteomics studies
  • Therapeutic response research

Compliance and Quality Assurance

  • IRB-approved and HIPAA-compliant protocols
  • Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
  • Documentation support available for regulatory review

Ordering and Customization

Uterine cancer plasma is available in standard and custom volumes. For international orders or documentation requirements, please email [email protected] to ensure compatibility with your country’s regulations.

Protocols and Documentation +

Document Type Technical Document
PDF > Plasma Isolation

Publications +

Data and Testing +

Data and Testing with Every Sample

  • Donor demographics
  • Donor-reported allergies
  • Donor-reported infectious disease history

Compliance & Quality Assured

For quality and compliance related information, please visit Sanguine quality and compliance page.

For privacy related information, please visit Sanguine privacy policy page.